Physician profile
Stephen J Wright
NPI 1235143439
$12,911.68
in general payments reported to CMS, 2019-2025
62 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $1,298 · 2021: $2,347 · 2022: $2,412 · 2023: $1,898 · 2024: $1,710 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,806 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,805.72 |
| Education | $181.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,517.35 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $1,379.51 | 2019-2025 | Vraylar, Ubrelvy, Lo Loestrin Fe |
| Astrazeneca Pharmaceuticals Lp | $1,016.40 | 2020-2025 | Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $994.07 | 2021-2025 | |
| Glaxosmithkline, LLC. | $841.77 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $696.34 | 2021-2025 | |
| Amgen INC. | $644.30 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $540.30 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $517.38 | 2019-2022 | |
| Astellas Pharma US INC | $513.47 | 2019-2025 | Veozah |
| Therapeuticsmd, INC. | $310.65 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $301.32 | 2021-2024 | Eliquis |
| Medtronic, INC. | $297.05 | 2022-2025 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $260.73 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $259.76 | 2019-2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $210.17 | 2021-2025 | Freestyle Libre 3, Xience Skypoint |
| Allergan, INC. | $199.87 | 2019-2020 | |
| Axsome Therapeutics, INC. | $170.04 | 2024-2025 | Auvelity, Sunosi |
| Inspire Medical Systems, INC. | $160.51 | 2025 | Inspire |
| Avion Pharmaceuticals | $131.56 | 2019-2022 | |
| Esperion Therapeutics, INC. | $125.48 | 2021-2024 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $121.31 | 2021-2024 | Trintellix |
| Exeltis, USA INC. | $112.59 | 2020-2023 | Slynd |
| Amarin Pharma, INC. | $106.29 | 2019 | |
| Merck Sharp & Dohme LLC | $105.74 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $97.62 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $93.34 | 2020-2023 | Nexletol, Contrave |
| Eisai INC. | $88.86 | 2020-2021 | |
| Halozyme INC | $78.36 | 2023 | |
| Boston Scientific Corporation | $70.64 | 2022-2024 | Ekosonic, Ranger |
| Jazz Pharmaceuticals INC. | $64.89 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $58.13 | 2019-2022 | |
| Insulet Corporation | $56.23 | 2025 | Omnipod |
| Biosense Webster, INC. | $55.54 | 2025 | Carto 3 |
| Exact Sciences Corporation | $49.92 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Evofem Biosciences, INC. | $44.79 | 2021 | |
| Aytu Biopharma, INC. | $43.19 | 2019 | |
| Horizon Therapeutics Plc | $41.69 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $41.18 | 2025 | Gemtesa |
| Phathom Pharmaceuticals, INC. | $35.65 | 2024-2025 | Voquezna |
| Teva Pharmaceuticals USA, INC. | $35.47 | 2021 | |
| Sanofi Pasteur INC. | $34.46 | 2019-2020 | |
| Antares Pharma, INC. | $33.13 | 2023-2024 | Xyosted, Tlando, Nocdurna |
| Hologic Sales and Service, LLC | $30.54 | 2022 | |
| Ucb, INC. | $27.44 | 2024 | Nayzilam |
| Alfasigma USA, INC. | $27.36 | 2020 | |
| Genentech USA, INC. | $26.70 | 2019 | |
| Biogen, INC. | $25.70 | 2023 | Spinraza |
| Optos, INC. | $21.94 | 2021 | |
| Edwards Lifesciences Corporation | $19.05 | 2025 | Sapien 3 Ultra Resilia |
| Baxter Healthcare | $18.62 | 2022 | |
| Tris Pharma INC | $18.12 | 2025 | Dyanavel Xr |
| Seqirus USA INC | $16.89 | 2025 | Fluad, Flucelvax |
| Harmony Biosciences LLC | $16.10 | 2025 | |
| Almatica Pharma LLC | $15.69 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.97 | 2021 | |
| Duchesnay USA Incorporated | $14.40 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $13.00 | 2022 | |
| Lupin INC. | $12.74 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $12.67 | 2022 | |
| Athena Bioscience, LLC | $11.39 | 2022 | |
| Sanofi-Aventis U.S. LLC | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.